You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Data & Resources

Access the latest data and resources on dolutegravir and our HIV medicines.

The Unity Tool
 

An interactive tool created by ViiV Healthcare in partnership with Healthcare Professionals and Patient Advisory Groups, to support self-reflection & conversations in the everyday lives of people living with HIV.

 

Read More

▼ These medicinal products are subject to additional monitoring. This will allow quick identification of new safety information.
Healthcare professionals are asked to report any suspected adverse reactions.

Trade marks are owned by or licensed to the ViiV Healthcare group of companies.

Reference:

  1. Cahn P et al. Presented at: International AIDS Conference; July 23-27, 2018; Amsterdam, Netherlands.